Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2001 (3), CD000546

Aversive Smoking for Smoking Cessation

Affiliations
Review

Aversive Smoking for Smoking Cessation

P Hajek et al. Cochrane Database Syst Rev.

Abstract

Background: Aversion therapy pairs the pleasurable stimulus of smoking a cigarette with some unpleasant stimulus. The objective is to extinguish the urge to smoke.

Objectives: This review has two aims: First, to determine the efficacy of rapid smoking and other aversive methods in helping smokers to stop smoking; Second, to determine whether there is a dose-response effect on smoking cessation at different levels of aversive stimulation.

Search strategy: We searched the Cochrane Tobacco Addiction Group trials register for studies which evaluated any technique of aversive smoking.

Selection criteria: Randomized trials which compared aversion treatments with 'inactive' procedures or which compared aversion treatments of different intensity for smoking cessation. Trials must have reported follow up of least six months from beginning of treatment.

Data collection and analysis: We extracted data in duplicate on the study population, the type of aversion treatment, the outcome measure, method of randomization and completeness of follow up. The outcome measure was abstinence from smoking at maximum follow up, using the strictest measure reported by the authors. Subjects lost to follow up were regarded as smokers. Where appropriate, we performed meta-analysis using a fixed effect model.

Main results: Twenty-five trials met the inclusion criteria. Twelve included rapid smoking and nine used other aversion methods. Ten trials included two or more conditions allowing assessment of a dose-response to aversive stimulation. The odds ratio (OR) for abstinence following rapid smoking compared to control was 1.98 (95% confidence intervals (CI): 1.36 to 2.90). Several factors suggest that this finding should be interpreted cautiously. A funnel plot of included studies was asymmetric, due to the relative absence of small studies with negative results. Most trials had a number of serious methodological problems likely to lead to spurious positive results. The only trial using biochemical validation of all self reported cessation gave a non-significant result. Other aversion methods were not shown to be effective (odds ratio 1.15, 95% confidence interval 0.73 to 1.82). There was a borderline dose-response to the level of aversive stimulation (OR 1.66, 95% CI: 1.00 to 2.78).

Reviewers' conclusions: The existing studies provide insufficient evidence to determine the efficacy of rapid smoking, or whether there is a dose-response to aversive stimulation. Milder versions of aversive smoking seem to lack specific efficacy. Rapid smoking is an unproven method with sufficient indications of promise to warrant evaluation using modern rigorous methodology.

Conflict of interest statement

Professor Hajek is a co‐author on one of the excluded studies (McRobbie 2007).

Figures

1.1
1.1. Analysis
Comparison 1 Rapid Smoking vs 'attention placebo' control, Outcome 1 Abstinence at long term follow up.
2.1
2.1. Analysis
Comparison 2 Other aversion method vs 'attention placebo' control, Outcome 1 Abstinence at long term follow up.
3.1
3.1. Analysis
Comparison 3 Dose Response (More aversive vs less aversive method), Outcome 1 Abstinence at long term follow up.

Update of

  • Aversive smoking for smoking cessation.
    Hajek P, Stead LF. Hajek P, et al. Cochrane Database Syst Rev. 2000;(2):CD000546. doi: 10.1002/14651858.CD000546. Cochrane Database Syst Rev. 2000. PMID: 10796558 Updated. Review.

Similar articles

  • Aversive smoking for smoking cessation.
    Hajek P, Stead LF. Hajek P, et al. Cochrane Database Syst Rev. 2000;(2):CD000546. doi: 10.1002/14651858.CD000546. Cochrane Database Syst Rev. 2000. PMID: 10796558 Updated. Review.
  • Electronic cigarettes for smoking cessation and reduction.
    McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. McRobbie H, et al. Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Cochrane Database Syst Rev. 2014. PMID: 25515689 Review.
  • Print-based self-help interventions for smoking cessation.
    Hartmann-Boyce J, Lancaster T, Stead LF. Hartmann-Boyce J, et al. Cochrane Database Syst Rev. 2014 Jun 3;(6):CD001118. doi: 10.1002/14651858.CD001118.pub3. Cochrane Database Syst Rev. 2014. PMID: 24888233 Updated. Review.
  • Nicotine replacement therapy for smoking cessation.
    Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Stead LF, et al. Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Cochrane Database Syst Rev. 2012. PMID: 23152200 Updated. Review.
  • Nicotine replacement therapy for smoking cessation.
    Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Silagy C, et al. Cochrane Database Syst Rev. 2004;(3):CD000146. doi: 10.1002/14651858.CD000146.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266423 Updated. Review.
See all similar articles

Cited by 19 articles

See all "Cited by" articles
Feedback